Can we optimize chemo-radiation and surgery in locally advanced stage III non-small cell lung cancer based on evidence from randomized clinical trials? A hypothesis-generating study

Radiotherapy and Oncology

Volumn 93, Issue 3, 2009, Pages 389-395

  De Ruysscher, Dirk ^a   Dehing, Cary ^b   Bentzen, Søren M ^d   Houben, Ruud ^b   Dekker, André ^b   Wanders, Rinus ^b   Borger, Jacques ^b   Hochstenbag, Monique ^a   Boersma, Liesbeth ^b   Geskes, Gijs ^a   Dingemans, Anne Marie C ^a   Bootsma, Gerben ^c   Lammering, Guido ^b   Lambin, Philippe ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRO CLINIC   (Netherlands)

^c Sittard Geleen Heerlen   (Netherlands)

^d UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Chemotherapy; Local tumor control; Non small cell lung cancer; Optimization; Radiotherapy; Surgery

Indexed keywords

CISPLATIN;

ADVANCED CANCER; ARTICLE; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; HUMAN; LUNG NON SMALL CELL CANCER; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL;

CARCINOMA, NON-SMALL-CELL LUNG; CLINICAL TRIALS, PHASE III AS TOPIC; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; HUMANS; LUNG NEOPLASMS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 70449644881     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2009.06.004     Document Type: Article

References (42)

1. Non-small Cell Lung Cancer Collaborative Group. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. Br Med J 311 (1995) 899-909
2. Fournel P., Robinet G., Thomas P., et al. Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer: Groupe Lyon-Saint-Etienne d'Oncologie Thoracique-Groupe Français de Pneumo-Cancérologie NPC 95-01 Study. J Clin Oncol 23 (2005) 5910-5917
3. Furuse K., Fukuoka M., Kawahara M., et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer. J Clin Oncol 17 (1999) 2692-2699
4. Curran W.J., Scott C.B., Langer C.J., et al. Long-term benefit is observed in a phase III comparison of sequential vs concurrent chemoradiation for patients with unresectable stage III nsclc: RTOG 94-10. Proc Am Soc Clin Oncol 22 (2003) 621a (Abstr 2499)
5. Zatloukal P., Petruzelka L., Zemanova M., et al. Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study. Lung Cancer 46 (2004) 87-98
6. Rowell N.P., and O'rourke N.P. Concurrent chemoradiotherapy in non-small cell lung cancer. Cochrane Database Syst Rev (2004) CD002140
7. Auperin A., Rolland E., Curran Jr. W., et al. Concomitant radio-chemotherapy (RT-CT) versus sequential RT-CT in locally advanced non-small cell lung cancer (NSCLC): a meta-analysis using individual patient data (IPD) from randomised clinical trials (RCTs). J Thorac Oncol 2 (2007) S310 (Abstr A1-05)
8. Albain K.S., Swann R.S., Rusch V.R., et al. Phase III study of concurrent chemotherapy and full course radiotherapy (CT/RT) versus CT/RT followed by surgical resection for stage IIIA(pN2) non-small cell lung cancer (NSCLC): outcomes update of North American Intergroup 0139 (RTOG 9309). J Clin Oncol 23 (2005) 624S (Abstr 7014)
9. Van Meerbeeck J., Kramer G.W., Van Schil P.E., et al. Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer. J Natl Cancer Inst 99 (2007) 442-450
10. Vansteenkiste J., Betticher D., Eberhardt W., et al. Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small cell lung cancer. J Thorac Oncol 2 (2007) 684-685
11. Albain K.S., Rusch V.W., Crowley J.J., et al. Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805. J Clin Oncol 13 (1995) 1880-1892
12. Pöttgen C., Eberhardt W., Bildat S., et al. Induction chemotherapy followed by concurrent chemotherapy and definitive high-dose radiotherapy for patients with locally advanced non-small-cell lung cancer (stages IIIa/IIIb): a pilot phase I/II trial. Ann Oncol 13 (2002) 403-411
13. Lorent N., De Leyn P., Lievens Y., et al. Long-term survival of surgically staged IIIA-N2 non-small-cell lung cancer treated with surgical combined modality approach: analysis of a 7-year prospective experience. Ann Oncol 15 (2004) 1645-1653
14. Betticher D.C., Hsu Schmitz S.F., Tötsch M., et al. Prognostic factors affecting long-term outcomes in patients with resected stage IIIA pN2 non-small-cell lung cancer: 5-year follow-up of a phase II study. Br J Cancer 94 (2006) 1099-1106
15. Garrido P., González-Larriba J.L., Insa A., et al. Long-term survival associated with complete resection after induction chemotherapy in stage IIIA (N2) and IIIB (T4N0-1) non small-cell lung cancer patients: the Spanish Lung Cancer Group Trial 9901. J Clin Oncol 25 (2007) 4736-4742
16. Martini N., Kris M.G., Flehinger B.J., et al. Preoperative chemotherapy for stage IIIa (N2) lung cancer: the Sloan-Kettering experience with 136 patients. Ann Thorac Surg 55 (1993) 1365-1373
17. Machtay M., Hsu C., Komaki R., et al. Effect of overall treatment time on outcomes after concurrent chemoradiation for locally advanced non-small-cell lung carcinoma: analysis of the Radiation Therapy Oncology Group (RTOG) experience. Int J Radiat Oncol Biol Phys 63 (2005) 667-671
18. De Ruysscher D., Pijls-Johannesma M., Bentzen S.M., et al. Time between the first day of chemotherapy and the last day of chest radiation is the most important predictor of survival in limited-disease small-cell lung cancer. J Clin Oncol 24 (2006) 1057-1063
19. Kim J.J., and Tannock I.F. Repopulation of cancer cells during therapy: an important cause of treatment failure. Nat Rev Cancer 5 (2005) 516-525
20. Wilson G.D., Bentzen S.M., and Harari P.M. Biologic basis for combining drugs with radiation. Semin Radiat Oncol 16 (2006) 2-9
21. Bentzen S.M., and Tucker S.L. Quantifying the position and steepness of radiation dose-response curves. Int J Radiat Biol 71 (1997) 531-542
22. Martel M.K., Ten Haken R.K., Hazuka M.B., et al. Estimation of tumor control probability model parameters from 3-D dose distributions of non-small cell lung cancer patients. Lung Cancer 24 (1999) 31-37
23. Le Chevalier T., Arriagada R., Quoix E., et al. Radiotherapy alone versus combined chemotherapy and radiotherapy in unresectable non-small cell lung cancer: first analysis of a randomised trial in 353 patients. J Natl Cancer Inst 83 (1991) 417-423
24. Le Chevalier T., Arriagada R., Tarayre M., et al. Significant effect of adjuvant chemotherapy on survival in locally advanced non-small-cell lung carcinoma [letter]. J Natl Cancer Inst 8 (1992) 58
25. Sause W., Scott C., Taylor S., et al. RTOG 88-08, ECOG 4588, preliminary results of a phase III trial in regionally advanced, unresectable non-small cell lung cancer. J Natl Cancer Inst 87 (1995) 198-205
26. Sause W., Kolesar P., Taylor S., et al. Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer. Chest 117 (2000) 358-364
27. Komaki R., Scott C.B., Sause T., et al. Induction cisplatin/vinblastine and irradiation vs irradiation in unresectable squamous cell lung cancer: failure patterns by cell type in RTOG 88-08/ECOG 4588. Int J Rad Oncol Biol Phys 39 (1997) 537-544
28. Vokes E.E., Herndon II J.E., Kelley M.J., et al. Induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for regionally advanced unresectable stage III non-small-cell lung cancer: cancer and leukemia group B. J Clin Oncol 25 (2007) 1698-1704
29. Dehing-Oberije C., De Ruysscher D., van der Weide H., et al. Tumor volume combined with number of positive lymph node stations is a more important prognostic factor than TNM stage for survival of non-small-cell lung cancer patients treated with (chemo)radiotherapy. Int J Radiat Oncol Biol Phys 70 (2008) 1039-1044
30. Fowler W.C., Langer C.J., Curran W.J., et al. Postoperative complications after combined neoadjuvant treatment of lung cancer. Ann Thorac Surg 55 (1993) 986-989
31. Deutsch M., Crawford J., Leopold K., et al. Phase II study of neoadjuvant chemotherapy and radiation therapy with thoracotomy in the treatment of clinically staged IIIA non-small cell lung cancer. Cancer 74 (1994) 1243-1252
32. Vora S.A., Daly B.D., Blaszkowsky L., et al. High dose radiation therapy and chemotherapy as induction treatment for stage III non-small cell lung carcinoma. Cancer 89 (2000) 1946-1952
33. Sonett J.R., Krasna M.J., Suntharalingam M., et al. Safe pulmonary resection after chemotherapy and high-dose thoracic radiation. Ann Thorac Surg 68 (1999) 316-320
34. Sonett J.R., Suntharalingam M., Edelman M.J., et al. Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer. Ann Thorac Surg 78 (2004) 1200-1205
35. Weitberg A.B., Liu L., Yashar J., et al. Twelve-year follow-up of trimodality therapy for stage IIIA non-small cell lung cancer. J Exp Clin Cancer Res 20 (2001) 335-340
36. Cerfolio R.J., Bryant A.S., Spencer S.A., et al. Pulmonary resection after high-dose and low-dose chest irradiation. Ann Thorac Surg 80 (2005) 1224-1230
37. Daly B.D., Fernando H.C., Ketchedjian A., et al. Pneumonectomy after high-dose radiation and concurrent chemotherapy for non-small cell lung cancer. Ann Thorac Surg 82 (2006) 227-231
38. Schild S.E., McGinnis W.L., Graham D., et al. Results of a Phase I trial of concurrent chemotherapy and escalating doses of radiation for unresectable non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 65 (2006) 1106-1111
39. Bentzen S.M. High-tech in radiation oncology: should there be a ceiling?. Int J Radiat Oncol Biol Phys 58 (2004) 320-330
40. Dehing-Oberije C., De Ruysscher D., van Baardwijk A., et al. The importance of patient characteristics for the prediction of radiation-induced lung toxicity. Radiother Oncol 91 (2009) 421-426
41. De Ruysscher D., Wanders S., van Haren E., et al. Selective mediastinal node irradiation on basis of the FDG-PET scan in patients with non-small cell lung cancer: a prospective clinical study. Int J Radiat Oncol Biol Phys 62 (2005) 988-994
42. De Ruysscher D., Botterweck A., Dirx M., et al. Eligibility for concurrent chemotherapy and radiotherapy of locally advanced lung cancer patients: a prospective, population-based study. Ann Oncol 20 (2009) 98-102